BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15254962)

  • 21. An autocrine loop directed by the vascular endothelial growth factor promotes invasiveness of human melanoma cells.
    Lacal PM; Ruffini F; Pagani E; D'Atri S
    Int J Oncol; 2005 Dec; 27(6):1625-32. PubMed ID: 16273219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584.
    Qian DZ; Wang X; Kachhap SK; Kato Y; Wei Y; Zhang L; Atadja P; Pili R
    Cancer Res; 2004 Sep; 64(18):6626-34. PubMed ID: 15374977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of VEGFR-2 on HaCaT cells is regulated by VEGF and plays an active role in mediating VEGF induced effects.
    Yang XH; Man XY; Cai SQ; Yao YG; Bu ZY; Zheng M
    Biochem Biophys Res Commun; 2006 Oct; 349(1):31-8. PubMed ID: 16930552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intra-amniotic infection upregulates decidual cell vascular endothelial growth factor (VEGF) and neuropilin-1 and -2 expression: implications for infection-related preterm birth.
    Snegovskikh VV; Schatz F; Arcuri F; Toti P; Kayisli UA; Murk W; Guoyang Luo ; Lockwood CJ; Norwitz ER
    Reprod Sci; 2009 Aug; 16(8):767-80. PubMed ID: 19474288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropilin2 expressed in gastric cancer endothelial cells increases the proliferation and migration of endothelial cells in response to VEGF.
    Kim WH; Lee SH; Jung MH; Seo JH; Kim J; Kim MA; Lee YM
    Exp Cell Res; 2009 Aug; 315(13):2154-64. PubMed ID: 19409892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased expression of VEGF-receptors (FLT-1, KDR, NRP-1) and thrombospondin-1 is associated with glomeruloid microvascular proliferation, an aggressive angiogenic phenotype, in malignant melanoma.
    Straume O; Akslen LA
    Angiogenesis; 2003; 6(4):295-301. PubMed ID: 15166498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelial differentiation of hematopoietic stem and progenitor cells from patients with multiple myeloma.
    Ria R; Piccoli C; Cirulli T; Falzetti F; Mangialardi G; Guidolin D; Tabilio A; Di Renzo N; Guarini A; Ribatti D; Dammacco F; Vacca A
    Clin Cancer Res; 2008 Mar; 14(6):1678-85. PubMed ID: 18347168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue factor pathway inhibitor-2 is upregulated by vascular endothelial growth factor and suppresses growth factor-induced proliferation of endothelial cells.
    Xu Z; Maiti D; Kisiel W; Duh EJ
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2819-25. PubMed ID: 17023682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upregulation of neuropilin-1 by basic fibroblast growth factor enhances vascular smooth muscle cell migration in response to VEGF.
    Liu W; Parikh AA; Stoeltzing O; Fan F; McCarty MF; Wey J; Hicklin DJ; Ellis LM
    Cytokine; 2005 Dec; 32(5):206-12. PubMed ID: 16289960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anthrax lethal toxin inhibits growth of and vascular endothelial growth factor release from endothelial cells expressing the human herpes virus 8 viral G protein coupled receptor.
    Depeille P; Young JJ; Boguslawski EA; Berghuis BD; Kort EJ; Resau JH; Frankel AE; Duesbery NS
    Clin Cancer Res; 2007 Oct; 13(19):5926-34. PubMed ID: 17908989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor.
    Lane HA; Wood JM; McSheehy PM; Allegrini PR; Boulay A; Brueggen J; Littlewood-Evans A; Maira SM; Martiny-Baron G; Schnell CR; Sini P; O'Reilly T
    Clin Cancer Res; 2009 Mar; 15(5):1612-22. PubMed ID: 19223496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropilin-1 forms complexes with vascular endothelial growth factor receptor-2 during megakaryocytic differentiation of UT-7/TPO cells.
    Ohsaka A; Hirota-Komatsu S; Shibata M; Komatsu N
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1171-6. PubMed ID: 19857463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells.
    Fujiyama S; Amano K; Uehira K; Yoshida M; Nishiwaki Y; Nozawa Y; Jin D; Takai S; Miyazaki M; Egashira K; Imada T; Iwasaka T; Matsubara H
    Circ Res; 2003 Nov; 93(10):980-9. PubMed ID: 14525810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular endothelial growth factor: a therapeutic target for tumors of the Ewing's sarcoma family.
    Dalal S; Berry AM; Cullinane CJ; Mangham DC; Grimer R; Lewis IJ; Johnston C; Laurence V; Burchill SA
    Clin Cancer Res; 2005 Mar; 11(6):2364-78. PubMed ID: 15788688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular endothelial growth factor induces branching morphogenesis/tubulogenesis in renal epithelial cells in a neuropilin-dependent fashion.
    Karihaloo A; Karumanchi SA; Cantley WL; Venkatesha S; Cantley LG; Kale S
    Mol Cell Biol; 2005 Sep; 25(17):7441-8. PubMed ID: 16107693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct signaling pathways confer different vascular responses to VEGF 121 and VEGF 165.
    Zhang Y; Furumura M; Morita E
    Growth Factors; 2008 Jun; 26(3):125-31. PubMed ID: 18569020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.
    Chung TW; Kim SJ; Choi HJ; Kim KJ; Kim MJ; Kim SH; Lee HJ; Ko JH; Lee YC; Suzuki A; Kim CH
    Glycobiology; 2009 Mar; 19(3):229-39. PubMed ID: 18974200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis.
    Cipriani P; Guiducci S; Miniati I; Cinelli M; Urbani S; Marrelli A; Dolo V; Pavan A; Saccardi R; Tyndall A; Giacomelli R; Cerinic MM
    Arthritis Rheum; 2007 Jun; 56(6):1994-2004. PubMed ID: 17530639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular endothelial growth factor (VEGF) signaling in tumor progression.
    Roskoski R
    Crit Rev Oncol Hematol; 2007 Jun; 62(3):179-213. PubMed ID: 17324579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of endothelium in the regulation of hematopoietic stem cell migration.
    Möhle R; Rafii S; Moore MA
    Stem Cells; 1998; 16 Suppl 1():159-65. PubMed ID: 11012158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.